The COVID-19 pandemic has demonstrated the urgent need to develop vaccine strategies optimized for pregnant people and their newborns, as both populations are at risk of developing severe disease. Although not included in COVID-19 vaccine development trials, pregnant people have had access to these vaccines since their initial release in the US and abroad. The rapid development and distribution of novel COVID-19 vaccines to people at risk, including those who are pregnant and lactating, presents an unprecedented opportunity to further our understanding of vaccine-induced immunity in these populations. In this review, we aim to summarize the literature to date on COVID-19 vaccination in pregnancy and lactation and highlight opportunities for investigation that may inform future maternal vaccine development and implementation strategies.

COVID-19 大流行表明迫切需要开发针对孕妇及其新生儿的疫苗策略，因为这两个人群都面临患上严重疾病的风险。尽管这些疫苗未纳入 COVID-19 疫苗开发试验，但自这些疫苗首次在美国和国外发布以来，孕妇就可以使用这些疫苗。新型 COVID-19 疫苗的快速开发和向高危人群（包括孕妇和哺乳期人群）的分发，为我们进一步了解这些人群中疫苗诱导的免疫力提供了前所未有的机会。在这篇综述中，我们旨在总结迄今为止有关妊娠期和哺乳期 COVID-19 疫苗接种的文献，并强调可能为未来孕产妇疫苗开发和实施策略提供信息的调查机会。